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Improved understanding of the epidemiology of Streptococcus equi transmission requires sensitive and
portable subtyping methods that can rationally discriminate between strains. S. equi is highly homogeneous
and cannot be distinguished by multilocus enzyme electrophoretic or multilocus sequence-typing methods that
utilize housekeeping genes. However, on sequence analysis of the N-terminal region of the SeM genes of 60
S. equi isolates from 27 strangles outbreaks, we identified 21 DNA codon changes. These resulted in the
nonsynonymous substitution of 18 amino acids and allowed the assignment of S. equi strains to 15 distinct
subtypes. Our data suggest the presence of multiple epitopes across this region that are subjected to selective
immune pressure (nonsynonymous-synonymous substitution rate [dN/dS] ratio  3.054), particularly during
the establishment of long-term S. equi infection. We further report the application of SeM gene subtyping as
a method to investigate potential cases of disease related to administration of a live attenuated S. equi vaccine.
SeM gene subtyping successfully differentiated between the vaccine strain and field strains of S. equi respon-
sible for concurrent disease. These results were confirmed by the development and application of a PCR
diagnostic test, which identifies the aroA partial gene deletion present in the Equilis StrepE vaccine strain.
Although the vaccine strain was found to be responsible for injection site lesions, all seven outbreaks of
strangles investigated in recently vaccinated horses were found to be due to concurrent infection with wild-type
S. equi and not due to reversion of the vaccine strain.
“Strangles,” caused by infection with the bacterium Strepto-
coccus equi, remains one of the most commonly diagnosed and
important infectious diseases of horses worldwide. The disease
is characterized by pyrexia, followed by profuse nasal discharge
and the formation of abscesses on the lymph nodes of the head
and neck, which subsequently burst, discharging highly infec-
tious pus. The swelling of the lymph nodes in the head and
neck may, in severe cases, restrict the airway, and it is this
clinical feature that gave the disease “strangles” its name (30).
Approximately 10% of horses that recover from strangles be-
come persistent carriers of S. equi, harboring the infectious
agent in chondroids located in the guttural pouch. These car-
riers are capable of infecting other naı¨ve horses and thereby
continuing the spread of disease (3, 20, 21). A particular prob-
lem in the management of strangles outbreaks is the lack of a
suitable assay to differentiate between S. equi strains and so to
determine if an outbreak is likely to be due to the recurrence
of an earlier infection or the introduction of a new S. equi
strain. Furthermore, in the absence of methods for subtyping
strains, it has not been possible to investigate whether S. equi
strain variation may contribute to the different presentations of
disease seen in different outbreaks.
The launch of Intervet’s “Equilis StrepE” live attenuated
strangles vaccine in 2004 has further highlighted the need to
distinguish between different strains of S. equi (7, 8). The
vaccine is recommended for use in horses at moderate to high
risk of developing strangles, including horses located on prem-
ises with a known history of strangles. The symptomatic ap-
pearance of concurrent S. equi infection may by chance coin-
cide with vaccination and may be misdiagnosed as an adverse
reaction to the vaccine. Therefore, the ability to differentiate
between the vaccine strain and wild-type S. equi would allow
the differentiation of concurrent disease from vaccine-derived
infection. Such information is valuable to the veterinary com-
munity, as it enables reliable assessment of vaccine safety in
the field.
S. equi strains are known to be highly homogeneous (5, 9).
To date, S. equi strains have been differentiated only by re-
striction fragment length polymorphism typing or repetitive
PCR (1, 28). However, these techniques are poorly portable,
and the variation that is indexed tends to change rapidly for
unknown reasons. Multilocus enzyme electrophoresis (MLEE)
analysis of 70 S. equi isolates placed 69 of them in a single
MLEE type (9). Recently, the availability of the S. equi ge-
nome sequence enabled us to identify a number of housekeep-
ing genes for the application of multilocus sequence typing
(MLST) techniques. However, in agreement with the MLEE
analysis, no variations in the sequences of the fba, gki, galU, xpt,
and recA genes were identified across 70 clinical isolates of S.
equi from disparate geographical sources (C. Robinson, un-
published results). The sequence typing of virulence genes or
hypervariable genes has been utilized to enhance the discrim-
inatory power of some MLST schemes (18, 25, 35). The short-
term variability of virulence genes is particularly suited to
studying local epidemiology (36) and allows the discrimination
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of different strains in the absence of variation in housekeeping
genes (33).
S. equi produces a novel M-like protein, SeM, which has
been linked to its increased virulence over its evolutionary
parent, Streptococcus zooepidemicus (4, 31). SeM actively binds
fibrinogen and immunoglobulin G (IgG) and inhibits the depo-
sition of C3b on the bacterial surface, resulting in an antiphago-
cytic action similar to that of the M proteins of group A
streptococci (2, 16) (Fig. 1). Vaccination with recombinant
SeM enhanced opsonization of S. equi in vitro (31) and pro-
tected mice against lethal challenge from S. equi (15). Despite
these encouraging data, use of purified SeM was not found to
confer significant protection on horses against subsequent
challenge with S. equi (26). SeM was thought to be highly
homogeneous because of the cross-reactivity of sera from a
horse convalescent from strangles with a number of different
S. equi isolates and the lack of variation in HindIII restriction
patterns between different S. equi isolates on Southern blot
analysis using a SeM gene probe (5). However, subsequent to
early reports, differences from the published sequence of the
SeM gene immediately after the N-terminal signal sequence
have been observed by two independent researchers on se-
quencing a limited number of S. equi isolates (3, 15). Many of
the changes identified altered the amino acid encoded, sug-
gesting the presence of distinct SeM gene subtypes.
The extent of SeM gene variation was determined in order
to evaluate the application of SeM gene sequencing to enhance
the epidemiological analysis of disease transmission. These
data were employed in the investigation of cases of strangles
occurring shortly after vaccination with Equilis StrepE. The
identity of the vaccine strain was confirmed with a diagnostic
PCR test based on the knowledge that the Equilis StrepE
strain is attenuated via a deletion in the aroA gene (http://www
.biosafety.be/EMEA/Table_EquilisStrepT.htm).
(Part of this work was summarized as a letter to the Veteri-
nary Record [22].)
MATERIALS AND METHODS
Bacterial strains. Details of all of the isolates examined in this study are
presented in Tables 1 and 2. Sixty S. equi isolates from 27 separate outbreaks
were obtained from swabs of suspected cases of strangles sent to the Animal
FIG. 1. Schematic representation of the SeM protein of S. equi. Amino acids 37 to 352 are required for fibrinogen binding (16). Amino acids
1 to 37 contain the M-protein signal sequence (ss) (31). Amino acids 37 to 184 (deleted) were found to be absent from 24% of S. equi strains
isolated from outwardly healthy horses (3). Amino acids 226 to 406 (central repeat region) contain the A and B repeat regions (31). Amino acids
482 to 534 contain the wall-spanning region and “LPSTG” cell wall anchor (cwa) (31). Amino acids 71 to 421 are required for IgG binding (17).
TABLE 1. SeM gene sequence types of isolates from clinical cases
of strangles and published literature
SeM
gene
allele
Source Outbreakno. Isolate(s)
Date of
isolationc
1 Netherlands NAa TW Not known
1 Sussex 1 6073 11/12/98
1 Ireland 2 SA 12/10/99
2 New York NA CF32 1981
2 Canadian 3 303 8/11/99
3 Hampshire NA 4047 1990
4 Berwickshire 4 0851, 0852 28/01/05
1458 22/02/05
2424 29/03/05
3731 11/05/05
5 Leicestershire 5 7325, 7326 8/12/03
6 Suffolk 6 7060, 7061, 7062,
7063, 7064,
7065, 7066
26/11/03
7094, 7098, 7099 27/11/03
7176 1/12/03
1610b 25/02/04
6 Gwent 7 7329 7/12/03
6 Sussex 8 7331 8/12/03
6 Wiltshire 9 7350, 7352 9/12/03
6 Aberdeenshire 10 1321 16/02/04
6 Kent 11 1351 16/02/04
6 Cheshire 12 7132 26/11/03
6 Hampshire 13 1218 12/02/05
6 Berwickshire 4 1165 10/02/05
3446 29/04/05
4289 27/05/05
7 Suffolk 6 1931, 1932 05/03/04
2077 10/03/04
8 Essex 14 1350 17/12/03
8 Buckinghamshire NA A1 1999
9 Hampshire 15 7344 8/12/03
10 Hampshire 16 7140 28/11/03
10 Shetland 17 7171 28/11/03
11 Suffolk 18 7364 10/12/03
12 Suffolk 19 3154 15/04/04
13 Suffolk 19 3155 15/04/04
14 Suffolk 19 3156 15/04/04
15 Australia 20 181063 27/09/99
a NA, not applicable.
b Isolate 1610 had gained a 6-amino-acid duplication, SEIAII, at codon 56.
c Day/month/year.
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Health Trust’s diagnostic laboratories from 1998 to 2005. A total of 15 of the
isolates were from suspected adverse reactions caused by the Equilis StrepE
vaccine. Of these, isolates 0223, R, and C were from lip injection site abscesses,
while the other strains were from suspected cases of strangles following vacci-
nation. The S. equi 4047 reference strain was isolated from a New Forest pony by
the Animal Health Trust and is the focus of the S. equi genome-sequencing
project at the Sanger Institute (http://www.sanger.ac.uk/Projects/S_equi/). The
SeM gene sequences for strains TW, CF32, and A1 have been previously pub-
lished and were included in our analysis (3, 15, 31). The TW928 strain was
isolated following plating of reconstituted Equilis StrepE vaccine (Intervet) onto
COBA Streptococcus selective agar (bioMe´rieux).
Identification of S. equi and DNA isolation. S. equi strains were isolated from
clinical swabs as beta-hemolytic colonies on COBA strep select plates (bioMe´rieux).
Their identities were confirmed by a lack of fermentation of trehalose, ribose,
and sorbitol in Purple broth (Becton Dickinson). A single colony of S. equi was
resuspended in 200 l gram-positive lysis solution (GenElute kit; Sigma) con-
taining 250 units/ml mutanolysin and 2  106 units/ml lysozyme and incubated
for 1 h at 37°C to allow efficient cell lysis. The DNA was then purified using
GenElute spin columns according to the manufacturer’s instructions (all Sigma).
PCR and sequencing of the SeM gene. The forward primer ASW73 (5-CAG
AAAACTAAGTGCCGGTG) and the reverse primer ASW74 (5-ATTCGG
TAAGAGCTTGACGC) were used to PCR amplify 541 bp of the N-terminal
region of the SeM gene unique to S. equi (Fig. 1) using Vent DNA polymerase
(New England BioLabs) with 30 cycles of 94°C for 30 s, 55°C for 30 s, and
72°C for 1 min. The PCR products were purified on QIAquick spin columns
(QIAGEN), and the sequences of both strands of the PCR fragments were
determined using an ABI3100 DNA sequencer with BigDye fluorescent termi-
nators and the primers used in the initial PCR amplification.
PCR and sequencing of the aroA gene. Amplification across the aroA gene
deletion present in the Equilis StrepE vaccine strain was performed using the
forward primer aroa1 (5-TTGCTGAGCTAATGCTGGTG) and the reverse
primer aroa2 (5-AACTGTCGTCTTGCCAACTC). These primers generated a
1,364-bp fragment from wild-type S. equi using Vent DNA polymerase (New
England BioLabs) with 30 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 3
min. To determine the nature of the aroA gene deletion in the Equilis StrepE
vaccine, the sequences of truncated PCR products generated from cultures of the
vaccine strain were determined as described above, using the aroa1 and aroa2
primers. To determine the 5 sequence of the full-length aroA gene, the primer
aroa5 (5-AACTCCTGACAGCCCTTTAC) was used instead of the aroa2
primer to generate a product of 503 bp, which included the first 464 bp of the
aroA gene, and it was sequenced as described above, using the aroa1 and aroa5
primers.
Analysis of sequence data. Sequence data were assembled using SeqMan 5.03
(DNAstar Inc.), and high-quality double-stranded-sequence data were used for
further analysis. Different SeM gene alleles were assigned to SeM gene se-
quences that differed from each other by one or more nucleotide differences. To
determine the level of selective pressure on the SeM gene, the nonsynonymous-
synonymous substitution rate (dN/dS) ratio was calculated by the Nei-Gojobori
method with Jukes-Cantor correction (19) using MEGA (11). A maximum like-
lihood tree was generated by PAUP version 4.0 (beta 10) (27) using likelihood
settings from the best-fit model (HKYG) selected by Modeltest 3.6 (24), and
visualized using TreeView (23).
RESULTS
PCR analysis of the SeM gene. PCR of the SeM genes of 60
clinical isolates of S. equi and the reference strains TW928 and
4047 generated products of 541 bp in all but one of the strains.
Strain 1610 was isolated 3 months after a strangles outbreak
from a pony with prolonged S. equi infection and generated a
PCR product of 559 bp.
Sequence analysis of the SeM gene. Analysis of the SeM gene
sequences from 60 clinical isolates of S. equi and comparison with
published SeM gene sequences identified 15 alleles (Table 3). Of
the 21 base changes identified across the 15 alleles, 18 resulted in
an altered amino acid sequence. The dN/dS ratio is used as a
measure of selective pressure at the protein level, with a ratio of
1 indicating positive selection. For this region of the SeM gene,
the dN/dS ratio was 3.054. A maximum likelihood tree of the SeM
gene alleles is shown in Fig. 2.
The most frequently identified SeM gene alleles were 6 and
9, which were present in nine and five strangles outbreaks,
respectively. Initial isolates from individual outbreaks were
generally found to have the same SeM gene allele. However,
an outbreak of strangles in three horses in Suffolk during 2004
generated three similar alleles: 12, 13, and 14 (Table 1). These
three alleles group together as a distinct branch of the phylo-
genetic tree (Fig. 2).
The SeM gene sequence of the CF32 S. equi strain (31)
shared the allele 2 sequence with Canadian field isolate 303
(Table 1). The A1 S. equi strain SeM gene (3) was found to be
allele 8, a sequence shared with field isolate 1350. The TW
strain (15) was found to have a SeM gene allele 1 also found in
isolates 6073 and SA (Table 1).
Analysis of isolates taken either early or late during an
outbreak of strangles in Suffolk demonstrated alteration of the
SeM gene sequence for the later isolates. Thus, all strains
initially isolated from 11 different horses suffering an outbreak
of strangles in Suffolk shared allele 6. However, the strains
1610, 1931, 1932, and 2077 isolated 3 months later from three
of these horses in the absence of clinical disease had different
SeM gene sequences (Table 1). Although the SeM gene allele
of 1610 remained similar to the initial isolates from this out-
break, the strain contained a duplication of 18 bp, resulting in
the insertion of a tandem repeat of the amino acids SEIAII at
amino acid position 56. Strains 1931, 1932 (both from the same
horse), and 2077 all contained identical G-to-A substitutions
at position 323, resulting in an arginine-to-histidine amino
acid change at codon 108 and leading to an allele switch from
6 to 7.
Characterization of postvaccination isolates. The Equilis
StrepE vaccine and strains 0223, R, and C isolated from lip
injection site reactions approximately 2 weeks postvaccination
with Equilis StrepE were found to share SeM gene allele 1
(Table 2). None of the isolates of S. equi from recently vacci-
nated or in-contact horses suffering from strangles were found
to have SeM gene allele 1 on sequencing, with the exception of
isolate 8689. However, isolate 8689 was obtained from a nasal
swab, and subsequent swabs from the discharging lymph nodes
of this horse (0353 and 0354) indicated the presence of a
different S. equi strain that had SeM gene allele 9 (Table 2),
which differs at four nucleotide positions (Table 3).
TABLE 2. SeM gene types of isolates from vaccinated horses
SeM
gene
allele
Source Outbreakno. Isolate(s)
Date of
isolationb
aroA
gene
PCR (bp)
1 Equilis StrepE vaccine NAa TW928 20/01/05 432
1 Cambridgeshire 21 8689 23/12/04 432
1 Berwickshire 4 0223 11/01/05 432
1 Berkshire 22 R, C 24/05/05 432
3 Berwickshire 4 199 8/01/05 1364
4 Berwickshire 4 0347 13/01/05 1364
7 Sussex 23 1974 11/03/05 1364
9 Cambridgeshire 21 0353, 0354 13/01/05 1364
9 Greater Manchester 24 1293 16/02/05 1364
9 Dorset 25 3081 19/04/05 1364
9 Surrey 26 3526 05/05/05 1364
10 Surrey 27 3679, 3680,
3682
10/05/05 1364
a NA, not applicable.
b Day/month/year.
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Strain 0347 isolated from a case of strangles in a horse
stabled next to a vaccinated horse was found to have SeM gene
allele 4 (Table 2), matching strains 0851 and 0852 isolated
from a suspected S. equi carrier located on the same premises
(Table 1). The carrier animal was sampled regularly by nasal
swab over the following 3 months, and the strains isolated
(1458, 2424, 1165, 3446, 3731, and 4289) were found to have
either allele 4 or 6, suggesting a mixture of infecting strains.
These two alleles differ by a G-to-A substitution at position
364, which results in a glycine-to-arginine amino acid change at
codon 122. Unfortunately, at the time of analysis, only a pure
culture from a single colony of each sample was available, and
so we were unable to determine the relative levels of these two
strains at any one time in this animal. S. equi strain 199, iso-
lated from a vaccinated pony also suffering from strangles on
these premises, had a SeM gene allele 3 originating from an
as-yet-unidentified source.
PCR of the aroA gene of the 4047 S. equi genome-sequenc-
ing strain generated a product of 1,364 bp. In contrast, aroA
gene PCR of DNA generated from the Equilis StrepE vaccine
yielded a 432-bp product. On sequencing the 432-bp product,
it was apparent that the Equilis StrepE strain lacks a region of
the aroA gene from positions 46 to 978.
PCR analysis of the aroA gene of clinical isolates taken from
recently vaccinated or in-contact horses that had subsequently
developed clinical signs of strangles was in agreement with the
SeM gene subtyping results. Thus, all of the isolates, with the
exception of 8689, yielded wild-type products of 1,364 bp, whereas
8689 yielded the 432-bp deleted aroA gene product, consistent
with this strain being derived from the vaccine strain (Table 2).
All isolates of S. equi from horses suffering from lip injection site
reactions following recent vaccination (0223, R, and C) generated
an aroA PCR product of 432 bp (Table 2). Sequencing of aroA
PCR products showed that they exactly matched either the full-
length aroA gene of the 4047 genome-sequencing strain or the
Equilis StrepE aroA deletion, in full agreement with the presence
of a wild-type S. equi or the vaccine strain. No sequence variation
in the aroA gene was observed.
FIG. 2. Maximum likelihood tree showing the relationships of the 15
different SeM gene sequence types of S. equi generated using PAUP
version 4.0 (27). Bootstrap values are shown for bipartitions supported by
50% of replicate trees (1,000 replicates were performed).
TABLE 3. SeM gene sequence types of S. equi
Allele
No. of isolates
(no. of
strangles
outbreaks)a
Amino acid at codon no.b:
41 54 58 62 63 65 78 90 92 104 107 108 110 122 125 127 143
1 2 (2)c Ser Asn Glu Ser Arg Ala Ala Leu Ser Asn Met His Ser Arg Ser Ala Ser
2 1 (1) * * Asp * Gly * * * * * * * * * * * Arg
3 1 (1) * * * * * * * * * * Val * * * * * *
4 6 (1) * * * * * * * Phe * * * Arg * Gly * * *
5 1 (1) Arg * Asp Asp * * Ala f * * Asng * Arg * * * Thr *
6 22 (9)d * * * * * * * Phe * * * Arg * * * * *
7 4 (2) * * * * * * * Phe * * * * * * * * *
8 1 (1) * * Asp * * * * * Pro * * * * * * * *
9 6 (5) * * Asp Asp * * * * * Asng * * * * * Thr *
10 5 (3) * * Asp Asp * * * * * * * * * * * Thr *
11 1 (1) * * Glue * Gly * * * * * * * * * * * Arg
12 1 (1) * Gly * * * Val * Phe * * * Arg * * Asn Ser *
13 1 (1) * Ser * * * Val * Phe * * * * Pro * Asn Ser *
14 1 (1) * Gly * * * Val * Phe * * * * Pro * Asn Ser *
15 1 (1) * * Glue * * * * * * * * Gln * * * * *
a Some outbreaks contained multiple S. equi subtypes.
b Amino acids differing from the majority are shown in boldface type. The asterisks indicate that the same codon is used as in allele 1.
c Does not include isolates of the Equilis StrepE vaccine.
d Does not include isolate 1610, which had a 6-amino-acid insertion into its MT6 sequence.
e Glu is encoded by GAG in MT11 and MT15 and by GAA in other MTs with a Glu codon.
f Ala is encoded by GCT in MT5 and by GCC in other MTs with an Ala codon.
g Asn is encoded by AAC in MT5 and MT9 and by AAT in other MTs with an Asn codon.
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DISCUSSION
SeM is a potent immunogenic and opsonogenic determinant
in S. equi (2, 29). A large proportion of antibody responses
generated in convalescent horses are directed toward the N
terminus (32). This region of SeM is responsible for fibrinogen
and IgG binding, both important antiphagocytic activities (16,
17). S. equi is believed to have evolved from a subtype of S.
zooepidemicus, and the acquisition of the SeM gene is believed
to have been an important step in this process (31). Searches of
recent S. zooepidemicus genome sequence data have identified
the presence of a SeM homologue distinct from those previ-
ously identified in S. zooepidemicus (http://www.sanger.ac.uk
/Projects/S_zooepidemicus). The H70 S. zooepidemicus SzM
has the least sequence homology between amino acids 36 and
186 of the SeM protein (Fig. 3). Therefore, rather than the
acquisition of the entire SeM gene, it may be the replacement
or modification of this N-terminal domain that is the evolu-
tionary step. It is interesting that deletion of regions of this
domain up to amino acids 37 to 183 was observed in S. equi
variants obtained from outwardly healthy horses (3). Sequenc-
ing of disparate strains of S. zooepidemicus is now required to
determine the extent of SzM gene variation and to ascertain if
this region is subjected to selective pressure from the immune
system during prolonged S. zooepidemicus colonization.
We have identified virulent S. equi strains that contain 15
different combinations of SeM gene sequence variations. Of
the 21 base changes identified in the SeM genes across 58 S.
equi isolates, 18 resulted in amino acid substitutions. This gen-
erated a dN/dS ratio of 3.054, indicating that the SeM gene is
under diversifying selection. An earlier report suggested that
there was no variation in the immunoreactivity of SeM extracts
from 21 different S. equi isolates (5). It will be interesting to
ascertain if the strains in that study have different SeM gene
alleles.
It is possible that the amino acid variations identified may
affect SeM function. Although determination of this was be-
FIG. 3. Alignment of S. equi 4047 SeM and S. zooepidemicus H70 SzM amino acid sequences. The dashes indicate a gap inserted to optimize
sequence alignment. The asterisks indicate identical amino acid residues. The colons indicate closely related nonidentical amino acid residues, and
the periods indicate similar amino acid residues. The signal sequence of S. equi is shown in boldface, the repeat domain is in italics, and the LPSTG
cell wall anchor motif is underlined.
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yond the scope of this paper, SeM gene alleles 1, 2, and 8 have
all been previously documented to bind fibrinogen (3, 15, 31).
It should also be noted that strains of each allele subtype were
responsible for producing disease in naturally infected horses,
although no direct comparison of the relative virulence of each
strain subtype was possible.
The SeM amino acid sequence was seen to change over time
in sequential isolates taken from one outbreak in Suffolk, in
which three horses suffered prolonged S. equi infection. These
results agreed with earlier observations that deletion of sec-
tions of the SeM gene encoding the fibrinogen binding domain
occur in 24% (4/17) of S. equi isolates from persistently in-
fected horses compared with only 0.6% (1/167) of S. equi
isolates from strangles cases (3). Such deletions were found to
result in decreased resistance to phagocytosis in vitro and were
postulated to lead to attenuation (3). However, a strain con-
taining a truncated SeM gene remained virulent in Welsh
mountain ponies (N. Chanter, unpublished results). S. equi
strains that alter their SeM gene sequences may achieve a
selective advantage in the host environment. Persistent S. equi
infections are believed to continually stimulate host tissues (20,
21, 34) and are likely to be subjected to continued selective
pressure. None of the S. equi isolates from four persistently
infected horses identified in this study contained SeM gene
deletions (isolate 1610 had actually gained a 6-amino-acid du-
plication), and all probably retained their full virulence. In-
deed, one carrier in Berwickshire was identified as a likely
source of allele 4 disease in a recently vaccinated horse. The
carrier was found to have a persistent sinus infection from
which we isolated S. equi strains with SeM gene alleles 4 and 6
that probably existed as a mixed infection.
One of the outbreaks sampled in this study (3154, 3155, and
3156) generated three similar SeM gene allele subtypes, 12, 13,
and 14, in the initial stages of disease from three different
horses. It is possible that this outbreak may have started
through contact of these horses with a long-term strangles
infection involving at least three SeM gene allele subtypes
probably originating from a single S. equi strain.
One model for the sequence variability observed for SeM is
that the alteration of one or more SeM epitopes in carrier
animals may be an important step in the establishment of a
persistent S. equi infection. Further studies that determine
sequential SeM gene sequence changes in a larger number of
horses during the development of long-term infection will yield
important information regarding the establishment of the car-
rier state and the targets of host selection. It is likely that other
S. equi surface proteins (6, 10, 12, 13, 14) will be subjected to
similar immune pressure during the establishment of the car-
rier state. These may also have varied amino acid sequences
that could be used as part of a multivirulence locus sequence-
typing system to further discriminate between S. equi isolates.
The Equilis StrepE vaccine strain (TW928) was found to
have SeM gene allele 1, shared by strain TW isolated from The
Netherlands (8), which was used to generate the vaccine strain.
Subsequent application of our subtyping methods enabled the
characterization of potential adverse reactions following vac-
cination with Equilis StrepE. The TW928 strain can clearly
persist in the lip injection site (0223, R, and C) and nasophar-
ynx (8689) shortly after vaccination. At the injection site, this
can lead to inflammation and the formation of abscesses, as
demonstrated by the three cases examined here. However,
none of the seven strangles outbreaks investigated to date in
vaccinated or in-contact horses appear to have been caused by
S. equi strains with the same SeM gene allele as the vaccine
strain, and all cases had a full-length aroA gene. To determine
if the deleted aroA gene could have been repaired by recom-
bination with S. zooepidemicus, we sequenced the first 464 bp
of the full-length aroA gene in these virulent strains. S. equi is
a clonal population, as determined by MLEE (9) and MLST
analyses of housekeeping genes (Robinson, unpublished),
while the aroA gene sequence of S. zooepidemicus strain H70
differs from that of S. equi 4047 at eight codons across this
464-bp coding section. Therefore, these or similar changes in
the aroA gene sequence should be present if the Equilis StrepE
strain had repaired its aroA gene by recombination with S.
zooepidemicus. All of these isolates contained a full-length aroA
gene, the sequence of the first 464 bp of which exactly matched
that of S. equi 4047, indicating that repair of the aroA gene
deletion by recombination with the common equine commen-
sal S. zooepidemicus was unlikely to have occurred. We con-
clude that the strangles in these vaccinated or in-contact horses
was most likely the result of concurrent disease, which had not
been prevented or caused by vaccination. Therefore, there is
currently no evidence that the Equilis StrepE vaccine strain
readily reverts to virulence in the field. These data suggest that
the deletion of part of the aroA gene in the Equilis StrepE
vaccine strain is both a stable and an effective method for
attenuation of S. equi.
Variations in the amino acid sequences of surface proteins
may influence their effectiveness as strangles vaccines (33). An
advantage of live attenuated vaccines, such as Equilis StrepE,
is that potentially protective immune responses to a number of
other cell surface proteins will be generated. However, it will
be interesting to determine if horses vaccinated with SeM gene
allele 1 Equilis StrepE vaccine remain protected from chal-
lenge with more disparate S. equi strains. The Arnica S. equi
strain used as a potential heterologous challenge in earlier
trials of the vaccine (8) has not yet been assigned a SeM gene
allele.
The assignment of an S. equi strain type based on the se-
quence of its SeM gene may assist veterinarians to rationally
differentiate between S. equi isolates and identify the source
and transmission of a particular outbreak. Submission of se-
quence data to generate a SeM gene allele profile and all of the
data presented in this study can be accessed at http://pubmlst
.org/szooepidemicus/seM/. It is hoped that such information
will improve the implementation of appropriate disease con-
trol and treatment strategies to reduce the risk of subsequent
strangles outbreaks and to learn more about the epidemiology
of disease transmission.
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